European Archives - Page 3 of 1428 - European Medical Journal

Pancreatic Tumour Survival Prediction Model

A validated nomogram predicts survival in solid pseudopapillary neoplasm, showing strong accuracy and clinical utility across training, validation, and external cohorts.

GLP-1 Agonists Lower Complications and Mortality in Pancreatitis

A large multicentre study finds GLP-1 receptor agonists do not increase pancreatitis risk and are associated with fewer complications and lower mortality in Type 2 diabetes.

Ending HIV Testing May Raise Infections 10% by 2030

Ending CDC-funded HIV testing could raise infections by 10%, with rural areas most affected, highlighting the key role of early diagnosis.

Paediatric Autoimmune Hepatitis Cases Rise in Denmark

Paediatric autoimmune hepatitis incidence in Denmark has surged, yet most children maintain liver function with standard immunosuppressive therapy.

Is England Struggling to Meet Rising PET-CT Needs?

England delivered 50% fewer PET-CT scans than guidelines recommend in 2021, with gaps for prostate cancer, neuroendocrine tumours, and dementia.

Atrial Fibrillation Treatment: Devices vs Anticoagulants

Non–procedure-related bleeding occurred in 10.9% of patients receiving left atrial appendage closure versus 19.0% of those on anticoagulants (hazard ratio: 0.55; 95% CI: 0.45–0.67; p

Total Working Hours Linked to Poor Sleep and Mental Health

Long total working hours, including unpaid care, affect sleep quality and mental health, especially in middle-aged women.

The Silent Pandemic: Modelling the Future of AMR

How can data reveal the hidden pathways of antimicrobial resistance? The EMJ Podcast continues its special AMR series, The Silent Pandemic.

Higher BMI May Protect Against Cardiovascular Events in CKD

A new study suggests that sustained higher BMI may reduce cardiovascular risk in chronic kidney disease, challenging traditional weight management approaches.

diabetes COVID

Prevalence of Incident Diabetes Increases After COVID-19 Infection

The prevalence of incident diabetes increases following COVID-19 infection, a 2026 systematic review and meta-analysis has revealed.